HeartSciences News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at HeartSciences

• Andrea Childs, Chief Executive Officer
• Bruce Bent, Director
• Brian Szymczak, Independent Director

Popular executive movements at HeartSciences

• Erik Ellingson has joined the company as Chief Financial Officer  (posted on June 29 2026).
• Andrew Simpson, Chief Executive Officer and Chairman of the Board, has left the company  (posted on June 29 2026).
• Andrea Childs has joined the company as Chief Executive Officer  (posted on June 29 2026).

Create your alert
to follow the executive moves at HeartSciences.

HeartSciences has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).
• Attovia Therapeutics has filed its IPO. Its stock ticker will be ATTO. (posted on July 15 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by HeartSciences

• News | HeartSciences
• News | HeartSciences
• News | HeartSciences
• News | HeartSciences

Social media about HeartSciences

• HeartSciences on Wikipedia, Google News & Yahoo Finance
• HeartSciences on LinkedIn, X (Twitter) & YouTube